However, coverage varies by plan
The recently launched SELECT cardiovascular outcomes trial is the first of its kindevaluating the cardiovascular benefits of weekly semaglutide in patients without diabetes but with a higher BMI (NCT03574597)
Younger consumers, particularly millennials and Gen Z, are driving adoption of anti-aging treatments, immune-supporting supplements, and detoxification products as part of comprehensive wellness strategies, while simultaneously, aging populations are seeking preventive solutions to address chronic disease risk and age-related decline
A key randomized trial conducted by the European Group for the Study of Graves Orbitopathy (EUGOGO) demonstrated that Se supplementation (200 g/day) reduced the severity of TED and improved quality of life in patients [80]
This larger supply reduces the need for reordering and supports multi-phase research protocols
Report any unusual symptoms like severe nausea, vomiting, or signs of dumping syndrome to both your bariatric team and your provider overseeing GLP-1 therapy
